H35.3134 Nonexudative age-related macular degeneration, bilateral, advanced atrophic with subfoveal involvement

Name of the Condition

• Nonexudative Age-Related Macular Degeneration, Bilateral, Advanced Atrophic with Subfoveal Involvement (H35.3134)

Summary

Nonexudative age-related macular degeneration (AMD) is a chronic eye condition affecting the macula, the central part of the retina responsible for sharp central vision. This bilateral, advanced atrophic form involves progressive macular thinning and cell loss without fluid leakage or bleeding. Subfoveal involvement indicates damage to the area directly beneath the fovea, which is critical for central vision. This stage is often referred to as "advanced dry AMD" and typically results in significant vision impairment.

Causes

The exact cause is unknown, but it involves the degeneration of retinal cells and the accumulation of drusen (yellow deposits) under the retina. Oxidative stress and impaired cellular debris removal are suspected contributors to the advanced atrophic process. Genetic factors may also play a role in disease progression.

Risk Factors

• Age (most common in individuals over 60)
• Family history of AMD
• Smoking
• High blood pressure and cholesterol
• Obesity
• Prolonged sunlight exposure
• Poor diet low in antioxidants

Symptoms

• Blurred or reduced central vision
• Difficulty recognizing faces
• Need for brighter light when reading
• Gradual difficulty adapting to low light levels
• Distorted or wavy vision (metamorphopsia)
• Central blind spots (scotomas)

Diagnosis

Diagnosis requires a comprehensive eye examination, including dilation to assess the macula. Optical coherence tomography (OCT) visualizes retinal layers and confirms atrophic changes. Fundus photography documents macular changes, and an Amsler grid test detects vision distortions. Fluorescein angiography may be used to rule out exudative components.

Treatment Options

• No cure exists, but progression can be slowed.
• Nutritional supplements (e.g., AREDS2 formula) may help slow advancement.
• Low-vision aids (magnifiers, specialized lighting) improve daily function.
• Referral to low-vision rehabilitation services.

Prognosis and Follow-Up

Prognosis is guarded due to irreversible macular damage. Vision loss is typically gradual but may stabilize. Regular follow-up with an ophthalmologist is essential to monitor for progression or conversion to exudative AMD. Frequency of visits depends on disease activity and individual risk factors.

Complications

• Irreversible central vision loss
• Difficulty with daily tasks (reading, driving, recognizing faces)
• Increased risk of falls due to poor depth perception
• Potential conversion to exudative AMD (wet form), which may require urgent treatment.

Lifestyle & Prevention

• Quit smoking to reduce progression risk.
• Maintain a diet rich in leafy greens, fish, and antioxidants.
• Protect eyes from UV light with sunglasses.
• Manage blood pressure and cholesterol levels.
• Exercise regularly to support overall vascular health.

When to Seek Professional Help

Seek immediate care if you experience sudden vision changes, such as new blind spots, distorted lines, or rapid vision loss, as these may indicate conversion to exudative AMD. Regular eye exams are recommended for those with AMD risk factors or existing diagnosis.

Tips for Medical Coders

Document the bilateral nature, advanced atrophic stage, and subfoveal involvement clearly in clinical notes. Ensure the diagnosis is supported by OCT findings or clinical examination. Subfoveal involvement should be explicitly stated to justify this specific code. Avoid using this code for non-bilateral or non-advanced cases.